2019 surveillance of lower urinary tract symptoms in men:management (NICE guideline CG97)
Closed for comments This consultation ended on at Request commenting lead permission
Research recommendations
2.1 Multichannel cystometry
What is the clinical and cost effectiveness of multichannel cystometry in improving patient‑related outcomes in men considering bladder outlet surgery?
Summary of findings
No new evidence relevant to the research recommendation was found and no ongoing studies were identified.
Surveillance proposal
This research recommendation will be considered again at the next surveillance point.
2.2 Catheterisation
What are the clinical and cost effectiveness and associated adverse events of intermittent catheterisation compared with indwelling catheterisation (suprapubic or urethral) for men with voiding difficulty and chronic retention of urine?
Summary of findings
No new evidence relevant to the research recommendation was found and no ongoing studies were identified.
Surveillance decision
This research recommendation will be considered again at the next surveillance point.
2.3 Products for men with urinary incontinence
What are the clinical and cost effectiveness and associated adverse events of absorbent pads compared with sheath collectors for men with urinary incontinence?
Summary of findings
No new evidence relevant to the research recommendation was found and no ongoing studies were identified.
Surveillance decision
This research recommendation will be considered again at the next surveillance point.
2.4 Male slings
In men with mild to moderate post prostatectomy urinary incontinence, what is the clinical and cost effectiveness of a male sling or an implanted adjustable compression device, when assessed by symptom severity, quality of life, changes in measured leakage and occurrence of adverse events?
Summary of findings
No new evidence relevant to the research recommendation was found and no ongoing studies were identified.
Surveillance decision
This research recommendation will be considered again at the next surveillance point.
2.5 Phosphodiesterase‑5‑inhibitors
What is the clinical and cost effectiveness of phosphodiesterase‑5 inhibitors (PDE5Is) for treating lower urinary tract symptoms in men who do not have erectile dysfunction?
Summary of findings
No new evidence relevant to the research recommendation was found and no ongoing studies were identified.
Surveillance decision
This research recommendation will be considered again at the next surveillance point.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
- Do you agree with the proposal not to update the guideline?
Please could let us know if you agree or disagree (yes/no) and provide with your comments regarding the sameQuestion on Consultation
- Do you have any comments on areas excluded from the scope of the guideline?
Please could let us know if you agree or disagree (yes/no) and also provide with your comments regarding the sameQuestion on Consultation
- Do you have any comments on equalities issues?
Please could let us know if you agree or disagree (yes/no) and also provide with your comments regarding the same